Current controversies in prenatal diagnosis 1: NIPT for chromosome abnormalities should be offered to women with lowa prioririsk†

    loading  Checking for direct PDF access through Ovid

Abstract

In its successful annual cycle of controversies and debates, the International Society of Prenatal Diagnosis and Therapy once again addressed non-invasive prenatal testing (NIPT) by following up on the 2013 controversy, ‘Should non-invasive DNA testing be the standard screening test for Down syndrome in all pregnant women’? with the proposition, ‘NIPT for chromosomel abnormalities should be offered to women with low a priori risk’. © 2014 John Wiley & Sons, Ltd.

Related Topics

    loading  Loading Related Articles